Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Zachary Eyre

Dermatology Atlanta, GA Medical Doctor

NPI 1568994085 CMS profile 9749251

3280 Howell Mill Rd Nw Ste 211, Atlanta, GA 30327

Open in the dashboard

General payments

$10,706

513 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Zachary Eyre of Atlanta, GA is reported in the CMS Open Payments database as having received $10,706 across 513 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,476 147
2024 General $2,525 112
2023 General $3,245 143
2022 General $1,851 84
2021 General $609 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary Eyre
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Zachary Eyre were reported at $2,476. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Zachary Eyre Dermatology median Middle half National median
2019 $0 $454 $129–$1,240 $163
2020 $0 $235 $81–$756 $114
2021 $609 $377 $108–$1,108 $132
2022 $1,851 $514 $143–$1,391 $149
2023 $3,245 $607 $159–$1,674 $160
2024 $2,525 $751 $204–$1,903 $164
2025 $2,476 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,630 89 payments
  2. Genzyme Corporation $1,372 40 payments
  3. Pfizer Inc. $1,296 70 payments
  4. Incyte Corporation $1,004 46 payments
  5. Regeneron Healthcare Solutions, Inc. $854 38 payments
  6. E.R. Squibb & Sons, L.L.C. $684 36 payments
  7. Lilly USA, LLC $454 22 payments
  8. Galderma Laboratories, L.P. $336 20 payments
  9. LEO Pharma Inc. $326 17 payments
  10. Amgen Inc. $326 14 payments
  11. Other $2,424 121 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,626 512 payments
  2. Education $80 1 payment
Products named General payments · program years 2021–2025
  1. DUPIXENT Immunology $1,540 41 payments
  2. CIBINQO $1,296 70 payments
  3. OPZELURA $1,004 46 payments
  4. RINVOQ $917 51 payments
  5. LITFULO $817 50 payments
  6. SOTYKTU $684 36 payments
  7. EUCRISA $664 35 payments
  8. SKYRIZI $545 26 payments
  9. DUPIXENT Inflammation And Immunology $494 20 payments
  10. Otezla $326 14 payments
  11. Other $4,006 210 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

331

Median for Dermatology: 534

Drug cost

$155,936

Median for Dermatology: $67,151

Branded share of claims

9.1%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Pen Dupilumab Brand 30 $150,129
Tacrolimus Generic 15 $2,345
Ketoconazole Generic 80 $957
Clindamycin Phosphate Generic 21 $707
Triamcinolone Acetonide Generic 71 $584
Doxycycline Hyclate Generic 25 $460
Minocycline Hcl Generic 12 $386
Hydrocortisone Generic 28 $147
Gabapentin Generic 23 $114
Prednisone Generic 15 $61

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$6,119

Medicare's payments for the services billed

Medicare patients

35

Average age 75

Services billed

128

12 women, 23 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 57%
Arthritis 31%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 29 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $386
  • Regeneron Healthcare Solutions, Inc. $145
$531 30 —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $294
$294 — —
RINVOQ
  • AbbVie, Inc. $214
$214 — —
SKYRIZI
  • AbbVie, Inc. $183
$183 — —
OPZELURA
  • Incyte Corporation $148
$148 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 29 with Patron

Records

513 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record